171 related articles for article (PubMed ID: 20830779)
1. Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function.
Alsultan A; Sokol RJ; Lovell MA; Thurman G; Ambruso DR
Pediatr Blood Cancer; 2010 Dec; 55(7):1410-3. PubMed ID: 20830779
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
3. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I.
Visser G; Rake JP; Fernandes J; Labrune P; Leonard JV; Moses S; Ullrich K; Smit GP
J Pediatr; 2000 Aug; 137(2):187-91. PubMed ID: 10931410
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease-like colitis in a young Turkish child with glycogen storage disease type 1b and elevated platelet count.
Saltik-Temizel IN; Koçak N; Ozen H; Yüce A; Gürakan F; Demir H
Turk J Pediatr; 2005; 47(2):180-2. PubMed ID: 16052862
[TBL] [Abstract][Full Text] [Related]
5. Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib.
Ishiguro A; Nakahata T; Shimbo T; Amano Y; Yasui K; Koike K; Komiyama A
Eur J Pediatr; 1993 Jan; 152(1):18-20. PubMed ID: 7680314
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.
Yamaguchi T; Ihara K; Matsumoto T; Tsutsumi Y; Nomura A; Ohga S; Hara T
Inflamm Bowel Dis; 2001 May; 7(2):128-32. PubMed ID: 11383585
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase activity and chemotaxis by neutrophils in two patients with glycogen storage disease type Ib treated with recombinant human granulocyte-monocyte colony-stimulating factor.
Piva E; De Toni S; Bovo C; Bordugo A; Burlina AB; Plebani M
Haematologica; 1996; 81(2):148-51. PubMed ID: 8641644
[TBL] [Abstract][Full Text] [Related]
8. Crohn's-like colitis in glycogen storage disease Ib: a case report.
Franceschini R; Gianetta E; Pastorino A; Dallegri F; Cataldi A; Corsini G; Barreca T
Hepatogastroenterology; 1996; 43(12):1461-4. PubMed ID: 8975948
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
Wang WC; Crist WM; Ihle JN; Arnold BA; Keating JP
Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246
[TBL] [Abstract][Full Text] [Related]
10. [Continuous treatment with colony stimulating factors (G-CSF) for neutropenia associated with type Ib glycogenosis].
de Diego Fernández P; García Fernández JR; Moreno Madrid F; Sánchez Forte M
An Esp Pediatr; 2001 Sep; 55(3):282-4. PubMed ID: 11676908
[TBL] [Abstract][Full Text] [Related]
11. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Wortmann SB; Van Hove JLK; Derks TGJ; Chevalier N; Knight V; Koller A; Oussoren E; Mayr JA; van Spronsen FJ; Lagler FB; Gaughan S; Van Schaftingen E; Veiga-da-Cunha M
Blood; 2020 Aug; 136(9):1033-1043. PubMed ID: 32294159
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.
Visser G; Rake JP; Labrune P; Leonard JV; Moses S; Ullrich K; Wendel U; Groenier KH; Smit GP
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S83-7. PubMed ID: 12373578
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b.
Volz MS; Nassir M; Treese C; von Winterfeld M; Plöckinger U; Epple HJ; Siegmund B
BMC Gastroenterol; 2015 Apr; 15():45. PubMed ID: 25881301
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
Chen LY; Shieh JJ; Lin B; Pan CJ; Gao JL; Murphy PM; Roe TF; Moses S; Ward JM; Lee EJ; Westphal H; Mansfield BC; Chou JY
Hum Mol Genet; 2003 Oct; 12(19):2547-58. PubMed ID: 12925567
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
16. Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report.
Rossi A; Miele E; Fecarotta S; Veiga-da-Cunha M; Martinelli M; Mollica C; D'Armiento M; Mozzillo E; Strisciuglio P; Derks TGJ; Staiano A; Parenti G
Ital J Pediatr; 2021 Jul; 47(1):149. PubMed ID: 34215305
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases.
Donadieu J; Bader-Meunier B; Bertrand Y; Lachaux A; Labrune P; Gougerot-Pocidalo MA; Odièvre M; Gibeaud P; Yver A; Tchernia G
Nouv Rev Fr Hematol (1978); 1994; 35(6):529-34. PubMed ID: 7512258
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.
Latger-Cannard V; Marchand-Arvier M; Vidailhet M; Donadieu J; Vigneron C; Bordigoni P
Eur J Pediatr; 2002 Feb; 161(2):87-93. PubMed ID: 11954758
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease in glycogen storage disease type Ib.
Roe TF; Thomas DW; Gilsanz V; Isaacs H; Atkinson JB
J Pediatr; 1986 Jul; 109(1):55-9. PubMed ID: 3459848
[TBL] [Abstract][Full Text] [Related]
20. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
